MedTrace Logo

Effect of Hydrogen-rich Water During Tapering on Recovery After Functional Overreaching in Basketball Players

NCT07714057 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-28

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate whether hydrogen-rich water supplementation during tapering improves recovery after functional overreaching in competitive male basketball players aged 18-35 years. The main questions it aims to answer are:

* Does hydrogen-rich water improve autonomic recovery after functional overreaching?
* Does hydrogen-rich water improve recovery in biochemical, performance, and subjective feeling outcomes during tapering?

Researchers will compare hydrogen-rich water to placebo (water containing no molecular hydrogen) to determine whether molecular hydrogen improves recovery after accumulated fatigue has been induced by functional overreaching. Participants will:

* Complete a training cycle including normal training, functional overreaching, and tapering.
* Consume hydrogen-rich or placebo water daily during the one-week tapering period.
* Undergo repeated testing of autonomic nervous system, blood biochemical markers, performance, and subjective soreness.

Conditions

  • Healthy Active Athletes

Interventions

DIETARY_SUPPLEMENT

Hydrogen-rich water

Hydrogen-rich water with molecular hydrogen concentration \>1.0 ppm.

DIETARY_SUPPLEMENT

Placebo water

Tap water without molecular hydrogen.

Sponsors & Collaborators

  • Palacky University

    lead OTHER

Principal Investigators

  • Jan Kvas · Palacky University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-27
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07714057 on ClinicalTrials.gov